- Michael Torok, co-founder of JEC Capital Partners, joins Amarin Corporation's board, expected to boost strategic initiatives.
- Analysts set Amarin Corp PLC's (AMRN, Financial) average price target at $1.00, indicating a sharp downside from the current stock price.
- The estimated GF Value suggests potential growth, indicating an upside from the present valuation.
Amarin Corporation (NASDAQ: AMRN) is making strategic moves as it welcomes Michael Torok, a co-founder and managing director at JEC Capital Partners, to its Board of Directors. Torok's financial acumen is anticipated to significantly contribute to the pharmaceutical company's endeavors to enhance shareholder value.
Wall Street Analysts Forecast
Current analyst predictions suggest a cautious outlook for Amarin Corp PLC (AMRN, Financial). The consensus among two analysts sets the average target price for the company at $1.00, with both the high and low estimates at $1.00. This target implies a considerable downside of 89.02% from the existing price of $9.11. For more in-depth analysis and projections, visit the Amarin Corp PLC (AMRN) Forecast page.
According to three brokerage firms' consensus, Amarin Corp PLC (AMRN, Financial) is currently rated as "Underperform," with an average recommendation of 3.7 on a scale where 1 is Strong Buy and 5 is Sell. This positions the stock as a potentially risky investment based on prevailing analyst opinions.
Evaluating GF Value
The GF Value for Amarin Corp PLC (AMRN, Financial) is estimated to be $10.66, indicating a potential upside of 17.01% from its current trading price of $9.11. GF Value is a metric used by GuruFocus to estimate the fair trading value of a stock, calculated based on historical trading multiples, past business growth, and projected future performance. Detailed data and analyses can be found on the Amarin Corp PLC (AMRN) Summary page.
